Newsletter | January 8, 2020

01.08.20 -- Acquiring And Implementing Innovation In The Pharmaceutical Industry

 
Featured Editorial
Acquiring And Implementing Innovation In The Pharmaceutical Industry
 
By Ed Miseta, chief editor, Clinical Leader

Pravin Jadhav has spent his entire career in the world of drug development. He is currently the senior director of applied innovation at Otsuka. Jadhav was a featured speaker at the recent CNS Summit in Boca Raton, and we took that opportunity to talk to him about innovation in the pharmaceutical industry and how companies can best acquire and implement new solutions.

Study Start-Up: The Case For A Sponsor Single Point Of Contact (SPoC) In Multicenter Trials
By Katherine Feldman

Every clinical start-up requires effective management of a discrete set of activities: the production of complete and compliant regulatory documents, efficient and comprehensive contract negotiations, accurate informed consent reviews, and timely institutional review board (IRB) submission and approval.

Industry Insights
Benefits Of Conducting Your Clinical Trial In Canada
Article | By Greg Keizer, Bellwyck Pharma Services

There are many advantages for companies that are based in the United States and Europe that are looking to bring their clinical trials to Canada. What makes Canada different?

Influence Of Size In CRO Selection
Article | By Rebecca McAvoy, ISR Reports

ISR surveyed hundreds of clinical development outsourcers about what they consider important when selecting providers. To capture the increasing role that preferred provider agreements are playing in the selection process respondents were asked about attribute importance in several scenarios.

The Value Of Data Standards In Clinical Trials: The Time Is Now
Article | By Terek Peterson, YPrime

On an organizational level, failure to establish data standards up front makes it difficult — and, in some cases, impossible — to connect data across disparate systems for efficient study execution. The adoption of data standards is necessary to underpin higher data quality, efficiencies, and integrated applications across increasingly complex clinical research processes. Continue reading to understand the history of data standards and where they are headed in the future.

Detecting, Handling, And Reporting Data Falsification, Misconduct, And/Or Suspected Fraud
Webinar | Rho

Whether indications of fraud appear as missing documentation, altered numbers, signatures that don’t match, or unavailable medical records, clinical research associates (CRAs) must be aware of the many signs of possible fraud or fabricated data occurring at a clinical trial site. This webinar explains the signs to look for and the proper protocol to handle and report the misconduct during each monitoring visit.

Sponsor
  ClinBiz Summit 2020
 

A place where clinical research professionals can connect on the latest topics, trends, and technologies for streamlining the business aspects of clinical trials, exploring topics such as:

  • Clinical Trial Outsourcing And Vendor Management
  • Clinical Trial Contracting And Budgeting
  • Clinical Trial Financial Management
  • Clinical Trial Business Operations
  • Accelerating Clinical Trial Start-Up Timelines
Events
DIA 2020 Global Annual Meeting
June 14 to 18, 2020
Washington, D.C.
Life Science Leader Magazine
 

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.

Connect With Clinical Leader:
   LinkedIn